Cargando…
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)
BACKGROUND: The global transition to use of dolutegravir (DTG) in WHO-preferred regimens for HIV treatment is limited by lack of knowledge on use in pregnancy. Here we assessed the relationship between drug concentrations (pharmacokinetics, PK), including in breastmilk, and impact on viral suppressi...
Autores principales: | Waitt, Catriona, Orrell, Catherine, Walimbwa, Stephen, Singh, Yashna, Kintu, Kenneth, Simmons, Bryony, Kaboggoza, Julian, Sihlangu, Mary, Coombs, Julie-Anne, Malaba, Thoko, Byamugisha, Josaphat, Amara, Alieu, Gini, Joshua, Else, Laura, Heiburg, Christie, Hodel, Eva Maria, Reynolds, Helen, Mehta, Ushma, Byakika-Kibwika, Pauline, Hill, Andrew, Myer, Landon, Lamorde, Mohammed, Khoo, Saye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754125/ https://www.ncbi.nlm.nih.gov/pubmed/31539371 http://dx.doi.org/10.1371/journal.pmed.1002895 |
Ejemplares similares
-
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1
por: Dickinson, Laura, et al.
Publicado: (2020) -
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019) -
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
por: Walimbwa, Stephen I., et al.
Publicado: (2021) -
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020) -
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)